Shaun O'Neil - 22 Feb 2022 Form 3/A - Amendment Insider Report for PAVmed Inc. (PAVM)

Role
Chief Operating Officer
Signature
/s/ Shaun O'Neil
Issuer symbol
PAVM
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
3/A - Amendment
Filing time
01 May 2023, 08:59:08 UTC
Date Of Original Report
24 Feb 2022
Next filing
06 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PAVM Common stock 288,954 22 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PAVM Employee stock option (right to buy) 22 Feb 2022 Common stock 195,108 $1.58 Direct F2
holding PAVM Employee stock option (right to buy) 22 Feb 2022 Common stock 100,000 $1.00 Direct F2
holding PAVM Employee stock option (right to buy) 22 Feb 2022 Common stock 75,000 $4.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 225,000 shares of restricted stock granted to the reporting person pursuant to the issuer's long term incentive equity plan.
F2 All options vest as to 1/12 of the shares on the first calendar quarter end after the grant date (i.e., on 9/30/18, 3/31/19 and 6/30/21 for the options expiring on 7/23/28, 3/6/29 and 3/31/31 respectively) and as to an additional 1/12 of the shares on each successive calendar quarter end thereafter.

Remarks:

This amendment was filed solely to correct (i) the number of shares of common stock held by the reporting person at the time of his appointment as a Section 16 officer of the issuer, as reflected in Table I and (ii) the expiration date of certain of the employee stock options reflected in Table II. The Form 4 filed by the reporting person 2/24/22 has not been amended to reflect the correction to Table I.